b'Allegra T. Aron, Ph.D., Assistant Professor, Department of Chemistry, University of Denverbeing harmless to being pathogenic, calledAll In for Patient Care The impact of pathobionts, use metals. More specifically, she is investigating the microbial communityAron also believes collaboration across fieldsthis research in the gastrointestinal tract. The goal is toand organizations is a huge part of being figure out how to hijack the metal uptakeall in for patient care. She appreciates thecould bepathways of these pathobionts in order toopportunity to forge partnerships across leverage them for targeted therapeutics.the state, including partnerships with indi- creatingviduals at the CU Anschutz Skaggs School of Similar to Quesada Tan, Aron is also workingPharmacy and Pharmaceutical Sciences andpersonalizedtoward a world in which medical treatmentsthe CU Anschutz School of Medicine. canbemorepersonalizedtoimproveWhether its improving a patients healingmedicine for outcomes and mitigate negative side effects of treatments.journey after a traumatic spinal cord injury orbetter patient researching how to leverage metals to create The impact of this research could be creatingmore targeted, narrow spectrum antibiotics,outcomes.personalized medicine for better patientthe Boettcher Investigators research plays a outcomes, and also thinking about how wemeaningful role in the all in approach neededALLEGRA T. ARON, Ph.D.can use narrow spectrum antibiotics to fightby Colorados health innovators to change livesASSISTANT PROFESSOR DEPARTMENT OF CHEMISTRYantibiotic resistance, said Aron.and the global health landscape.UNIVERSITY OF DENVER2024-2025 BIOSCIENCE COLORADO 43'